Dietmar Hopp Stiftung   Report issue

Foundation Phase 3
Founded: Germany (1995)

Organization Overview

First Clinical Trial
2003
NCT00259545
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now